IBMIBM

$253.52-6.4% 1Y

$253.52

$206.1552 weeks$329.23

Is the price fair?

Fair

Neither cheap nor expensive: growth expectations in line with delivery and in its normal P/E range.

2 neutral, 1 without data

What the price assumes~+3% a yearderived · Sep 30, 2026

Priced for ~3% a year FCF growth. Roughly in line with its three-year revenue growth of 5% a year.

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 21.6 vs a 17.5 median over 42 quarters (+23% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market

FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

IBM trades at 21.6× earnings against 19.8× for the median Information Technology Services name, more expensive than its own group.

21.6

Trailing P/E · Information Technology Services median 19.8 · 1.09× the median: the market pays up for this one

Price / sales: 3.43
Price / sales · today's price, trailing year to Sep 30, 2026
Free cash flow yield: 6.1%
Free cash flow yield · Information Technology Services median 8.2%
Growth the price implies: +3.0%
Growth the price implies · The price pays for +3.0% free cash flow growth a year for a decade; the business has delivered +6.7% a year over the last three.

Details›

What the market has paid for these earnings: 42 quarters of its own multiple × $11.75 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$120.79
Its own P/E history, median	$205.86
Its own P/E history, upper quartile	$281.56
52-week range	$206.15 – $329.23
Today	$253.52

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.